Takeda Licenses Global Rights to Theravance Biopharma's TD-8954, a Novel 5-HT4 Agonist and Motility Agent for Gastrointestinal ...
DUBLIN, IRELAND and OSAKA, JAPAN -- (Marketwired) -- 06/08/16 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Takeda Pharmaceutical Company Limited (TSE: 4502) ("Takeda") today announced that the companies have …